OncoVEX GALV/CD

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameOncoVEX GALV/CD
Drug Alias Nameoncolytic HSV therapy expressing cytosine deaminase (BioVex)
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCytosine deaminase stimulants
TargetsCytosine deaminase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiovex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiovex Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A